| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4051683
[patent_doc_number] => 05932541
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-03
[patent_title] => 'Method of adjusting the circadian rhythm of a mammal'
[patent_app_type] => 1
[patent_app_number] => 9/051860
[patent_app_country] => US
[patent_app_date] => 1998-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3496
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/932/05932541.pdf
[firstpage_image] =>[orig_patent_app_number] => 051860
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/051860 | Method of adjusting the circadian rhythm of a mammal | Aug 19, 1998 | Issued |
Array
(
[id] => 4094248
[patent_doc_number] => 06048532
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-04-11
[patent_title] => 'Chemical composition and method for aiding the absorption, binding and elimination of undigested fat and reducing cholesterol in the human body'
[patent_app_type] => 1
[patent_app_number] => 9/135920
[patent_app_country] => US
[patent_app_date] => 1998-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3339
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/048/06048532.pdf
[firstpage_image] =>[orig_patent_app_number] => 135920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/135920 | Chemical composition and method for aiding the absorption, binding and elimination of undigested fat and reducing cholesterol in the human body | Aug 17, 1998 | Issued |
| 09/135933 | CHEMICAL COMPOSITION AND METHOD FOR MORE RAPIDLY AIDING THE ABSORPTION, BINDING AN ELIMINATION OF UNDIGESTED FAT IN THE HUMAN BODY | Aug 17, 1998 | Issued |
Array
(
[id] => 4065730
[patent_doc_number] => 06008207
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Anhydrous alendronate monosodium salt formulations'
[patent_app_type] => 1
[patent_app_number] => 9/133200
[patent_app_country] => US
[patent_app_date] => 1998-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1700
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/008/06008207.pdf
[firstpage_image] =>[orig_patent_app_number] => 133200
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/133200 | Anhydrous alendronate monosodium salt formulations | Aug 12, 1998 | Issued |
Array
(
[id] => 4217422
[patent_doc_number] => 06087360
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-11
[patent_title] => 'Method of treating heart failure with endothelin antagonists'
[patent_app_type] => 1
[patent_app_number] => 9/132514
[patent_app_country] => US
[patent_app_date] => 1998-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 23
[patent_no_of_words] => 14654
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/087/06087360.pdf
[firstpage_image] =>[orig_patent_app_number] => 132514
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/132514 | Method of treating heart failure with endothelin antagonists | Aug 10, 1998 | Issued |
Array
(
[id] => 3944674
[patent_doc_number] => 05990159
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-23
[patent_title] => 'Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors'
[patent_app_type] => 1
[patent_app_number] => 9/117974
[patent_app_country] => US
[patent_app_date] => 1998-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3870
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/990/05990159.pdf
[firstpage_image] =>[orig_patent_app_number] => 117974
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/117974 | Use of 5HT4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors | Aug 10, 1998 | Issued |
Array
(
[id] => 3975994
[patent_doc_number] => 05916913
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-06-29
[patent_title] => 'Inhibition of wound contraction with paclitaxel, colchicine and penicillamine'
[patent_app_type] => 1
[patent_app_number] => 9/128031
[patent_app_country] => US
[patent_app_date] => 1998-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 4012
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/916/05916913.pdf
[firstpage_image] =>[orig_patent_app_number] => 128031
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/128031 | Inhibition of wound contraction with paclitaxel, colchicine and penicillamine | Aug 2, 1998 | Issued |
Array
(
[id] => 4011528
[patent_doc_number] => 05962536
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'Injectable propofol formulations'
[patent_app_type] => 1
[patent_app_number] => 9/127082
[patent_app_country] => US
[patent_app_date] => 1998-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1104
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962536.pdf
[firstpage_image] =>[orig_patent_app_number] => 127082
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/127082 | Injectable propofol formulations | Jul 30, 1998 | Issued |
| 09/101772 | MEDICAMENTS CONTAINING AROMATIC AZO COMPOUNDS | Jul 20, 1998 | Abandoned |
Array
(
[id] => 3925074
[patent_doc_number] => 05945435
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Levobupivacaine and its use'
[patent_app_type] => 1
[patent_app_number] => 9/119910
[patent_app_country] => US
[patent_app_date] => 1998-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 2870
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945435.pdf
[firstpage_image] =>[orig_patent_app_number] => 119910
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/119910 | Levobupivacaine and its use | Jul 20, 1998 | Issued |
| 09/117334 | ISCHEMIC HEART MUSCLE PROTECTIVE AGENTS | Jul 16, 1998 | Abandoned |
Array
(
[id] => 4132475
[patent_doc_number] => 06034109
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-03-07
[patent_title] => 'Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia'
[patent_app_type] => 1
[patent_app_number] => 9/118521
[patent_app_country] => US
[patent_app_date] => 1998-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 16
[patent_no_of_words] => 14167
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/034/06034109.pdf
[firstpage_image] =>[orig_patent_app_number] => 118521
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/118521 | Method for protection of heart by limiting metabolic and ionic abnormalities developed during ischemia following ischemia or resulting from ischemia | Jul 16, 1998 | Issued |
| 09/114114 | USE OF 4-ANDROSTENEDIOL TO INCREASE TESTOSTERONE LEVELS IN HUMANS | Jul 12, 1998 | Issued |
Array
(
[id] => 3928582
[patent_doc_number] => 05972340
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-26
[patent_title] => 'Slimming cream based on plants'
[patent_app_type] => 1
[patent_app_number] => 9/011319
[patent_app_country] => US
[patent_app_date] => 1998-07-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3670
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/972/05972340.pdf
[firstpage_image] =>[orig_patent_app_number] => 011319
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/011319 | Slimming cream based on plants | Jul 9, 1998 | Issued |
Array
(
[id] => 4416793
[patent_doc_number] => 06224861
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-05-01
[patent_title] => 'Amino acid composition'
[patent_app_type] => 1
[patent_app_number] => 9/112354
[patent_app_country] => US
[patent_app_date] => 1998-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 21
[patent_no_of_words] => 5732
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/224/06224861.pdf
[firstpage_image] =>[orig_patent_app_number] => 112354
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/112354 | Amino acid composition | Jul 8, 1998 | Issued |
Array
(
[id] => 4133489
[patent_doc_number] => 06121249
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins'
[patent_app_type] => 1
[patent_app_number] => 9/108765
[patent_app_country] => US
[patent_app_date] => 1998-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 4145
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121249.pdf
[firstpage_image] =>[orig_patent_app_number] => 108765
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/108765 | Treatment and prevention of cardiovascular diseases with help of aspirin, antioxidants, niacin, and certain B vitamins | Jun 30, 1998 | Issued |
Array
(
[id] => 4223666
[patent_doc_number] => 06011035
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-01-04
[patent_title] => 'Calcium channel blockers'
[patent_app_type] => 1
[patent_app_number] => 9/107037
[patent_app_country] => US
[patent_app_date] => 1998-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 2
[patent_no_of_words] => 4590
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/011/06011035.pdf
[firstpage_image] =>[orig_patent_app_number] => 107037
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/107037 | Calcium channel blockers | Jun 28, 1998 | Issued |
Array
(
[id] => 4143878
[patent_doc_number] => 06031000
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-29
[patent_title] => 'Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use'
[patent_app_type] => 1
[patent_app_number] => 9/102941
[patent_app_country] => US
[patent_app_date] => 1998-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6297
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/031/06031000.pdf
[firstpage_image] =>[orig_patent_app_number] => 102941
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/102941 | Composition comprising .beta.-hydroxy-.beta.-methylbutyric acid and at least one amino acid and methods of use | Jun 22, 1998 | Issued |
Array
(
[id] => 3947242
[patent_doc_number] => 05998458
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Method of treating heart failure'
[patent_app_type] => 1
[patent_app_number] => 9/100497
[patent_app_country] => US
[patent_app_date] => 1998-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7402
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998458.pdf
[firstpage_image] =>[orig_patent_app_number] => 100497
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/100497 | Method of treating heart failure | Jun 18, 1998 | Issued |
Array
(
[id] => 3977361
[patent_doc_number] => 05905078
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-18
[patent_title] => 'Use of a pyridazinone derivative'
[patent_app_type] => 1
[patent_app_number] => 9/099945
[patent_app_country] => US
[patent_app_date] => 1998-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1666
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/905/05905078.pdf
[firstpage_image] =>[orig_patent_app_number] => 099945
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/099945 | Use of a pyridazinone derivative | Jun 18, 1998 | Issued |